According to the lingzhi product market report released by QYR Consulting, this report provides information on the market situation, definition, classification, applications, and industrial chain structure of lingzhi products. It also discusses development policies, plans, manufacturing processes, and cost structures, while analyzing the current development status and future market trends of the lingzhi product market. Additionally, it analyzes the key production regions, major consumption regions, and leading manufacturers of the lingzhi product market from both production and consumption perspectives.
According to the latest research data from QYR Consulting, the global lingzhi product market scale reached 41.44 billion yuan in 2024. It is expected to expand steadily at a Compound Annual Growth Rate (CAGR) of 6.8%, and the market scale is likely to exceed 63.96 billion yuan by 2031. This growth rate highlights the market potential of lingzhi as a benchmark product of "food-medicine homology". Especially against the backdrop of global health consumption upgrading, accelerated internationalization of traditional Chinese medicine (TCM), and the surge in demand for functional foods, its dual value of "immune regulation + anti-aging" is driving the industry into a golden development period.
Lingzhi products take Ganoderma lucidum as the core raw material and are processed into health products, foods, pharmaceuticals, and cosmetics through modern biotechnology. Their pharmacological activities cover immune regulation, anti-tumor, anti-oxidation, and other aspects. Lingzhi is praised as a "top-grade" herb in The Divine Farmer's Classic of Materia Medica, and modern research has further confirmed that its components such as Ganoderma lucidum polysaccharides and triterpenoids have significant biological activities. With the advancement of the "Healthy China 2030" strategy and the global consumers' preference for natural therapies, the lingzhi industry has formed a full industrial chain system from cultivation to end-consumption.
In 2025, changes in the global geopolitical pattern and the deepening of enterprise digital transformation have exerted multi-dimensional impacts on the lingzhi product market:
- Accelerated standard development: China has issued the Regulations on the Administration of Food-Medicine Homology Substances, promoting the standardization of the entire process of lingzhi cultivation, processing, and testing.
- Regional market differentiation: North America has become the largest market due to its over 70% functional food penetration rate. Meanwhile, the Asia-Pacific region (especially China and Japan), supported by cultural recognition and policies, has emerged as the fastest-growing region.
- Upgraded technical barriers: To cope with international market competition, leading enterprises have increased R&D investment in core technologies such as lingzhi spore wall-breaking technology and stable preservation of active ingredients, building a competitive moat with quality advantages.
From the perspective of manufacturers, the global lingzhi product market presents a competitive pattern of "local brands dominating culturally recognized markets + multinational enterprises laying out high-end segments". Core manufacturers include:
- Local leaders: Enterprises such as Shinpire (China), Guangzhou Baiyunshan Pharmaceutical Group (China), and Yunnan Baiyao Group (China) rely on the brand momentum of "time-honored Chinese brands" and full industrial chain layout, occupying over 60% of the Chinese market share.
- Multinational enterprises: Kobayashi Pharmaceutical Co., Ltd. (Japan) and Korea Ginseng Corp (South Korea) have formed differentiated competitiveness in the high-end European and American markets through modern preparation technologies and international certifications.
- Regional characteristic manufacturers: Cooperatives in the Dabie Mountain Area of Anhui (China) and Lingzhi Industrial Park in Huzhou, Zhejiang (China) have established origin-direct supply models relying on geographical indication product certifications.
Data shows that during the historical cycle of 2020-2024, leading manufacturers consolidated their market positions through lingzhi variety improvement (e.g., hybrid varieties of red lingzhi and purple lingzhi) and deep processing technologies (e.g., supercritical CO₂ extraction). Emerging brands, meanwhile, achieved market share breakthroughs through live-streaming e-commerce.
Major producing areas in China such as Fujian, Zhejiang, and Yunnan have adopted wild-simulated cultivation technology, increasing the Ganoderma lucidum polysaccharide content to over 1.8% (compared with only 1.2% in traditional cultivation). They have also established a "cooperative + farmer" model to achieve standardized management. Data in 2025 shows that the organic lingzhi planting base in Guan County, Shandong has reached 50,000 mu (approximately 3,333 hectares), with per-mu yield increasing by 40% compared with 2020.
Enterprises have adopted low-temperature wall-breaking technology (wall-breaking rate ≥ 98%) and nano-encapsulation technology, increasing the absorption rate of active ingredients in lingzhi spore powder by 3 times. Product forms have extended from traditional lingzhi slices and lingzhi wine to portable strip packaging and compound formulas (e.g., lingzhi + American ginseng), meeting the needs of segmented scenarios such as sports populations and the elderly.
E-commerce platforms contribute over 55% of sales. Among them, the Gross Merchandise Volume (GMV) of the lingzhi category on Douyin E-commerce increased by 210% year-on-year from January to April 2025. Leading brands have increased the average customer price from 300 yuan to over 800 yuan through the "traceability live streaming + expert popular science" model.
The report focuses on five major global regional markets: North America, Europe, China, Japan, and Southeast Asia. The current development status and trends of each regional market are as follows:
- North American market: Lingzhi products account for 28% of functional food consumption in the United States. Brands such as Palo Alto Nutra occupy the high-end market through the Amazon Prime membership system.
- European market: Demand for organically certified lingzhi extracts in Germany increases by 35% annually. Local brands such as Dr. Wolz have established professional trust relying on clinical research data.
- Chinese market: Policies promote the "TCM inheritance and innovation" strategy. The CAGR is expected to reach 7.9% from 2025 to 2031, with new dosage forms such as lingzhi spore powder soft capsules leading consumption upgrading.
- Japanese market: The Kampo Medicine Revitalization Program has driven the sales of lingzhi tea drinks. Suntory Group launched a functional drink of "lingzhi + matcha", with monthly sales exceeding 1 million cans.
- Gene-editing breeding: CRISPR technology is used to improve lingzhi varieties, increasing the triterpenoid content by 200%.
- Intelligent extraction process: Continuous countercurrent extraction technology shortens the production cycle and reduces energy consumption by 30%.
- Precision nutrition customization: An AI-based physical condition testing system for lingzhi formula recommendation realizes personalized health management.
- Shift in competition focus: Competition shifts from price to the content of active ingredients and clinical verification data. Leading manufacturers consolidate their advantages by building a full-chain quality control system covering "raw materials - extraction - end products".
- Rise of emerging brands: Relying on live-streaming e-commerce and Direct-to-Consumer (DTC) models, small and medium-sized innovative enterprises may break the traditional competitive pattern in segmented fields.
- Accelerated international certification: EU Organic Certification (EOS) and US FDA GRAS Certification (Generally Recognized as Safe) have become access thresholds for the high-end market, forcing the industry to upgrade standardization.
- An anti-aging clinic in Japan: After using high-purity lingzhi extracts (content ≥ 30%), the average level of customers' immunoglobulin G increased by 22%, and the revisit rate reached 85%.
- A Chinese e-commerce brand: Through the innovation of "nitrogen-fresh-keeping strip packaging of lingzhi spore powder", the unboxing rate increased from 65% to 92%, and the annual repurchase rate grew by 4 times.
- From January to April 2025, the export volume of Chinese lingzhi products increased by 18.7% year-on-year, with the US market accounting for an increased proportion of 39%.
- The R&D investment of leading manufacturers has reached 9.3% of their revenue, an increase of 3.7 percentage points compared with 2020. The number of patents for lingzhi triterpenoids increases by 61% annually on average.
The global lingzhi product market is in a golden period driven by both cultural revival and technological innovation. Although it faces challenges such as intensified international market competition and standardization construction, the long-term trends of health consumption upgrading, TCM globalization, and biotechnology breakthroughs still provide strong growth momentum for the industry. For manufacturers, deepening variety improvement, optimizing omni-channel layout, and strengthening clinical verification data will be the core strategies to win the future market.
